Internal Medicine, Medical Oncology · Neptune, NJ
NPI
1083860944
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
19 Davis Ave Fl 2
Neptune, NJ, 07753
Phone (732) 367-1535
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
7,719 services
Medicare patients, 2024
112
Average age 74
Drug cost, 2024
$3.2M
1,448 prescriptions
Company payments, 2025
$794
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly W Fitzpatrick was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 974 times for 86 patients. In total Kelly W Fitzpatrick billed 7,719 services in 25 codes, and Medicare paid $254K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 974 | 86 | $13.57 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 660 | 43 | $97.07 | $64K |
| 99214 Office E&M - Established | Office | 659 | 60 | $107.33 | $71K |
| 99215 Office E&M - Established | Office | 460 | 69 | $150.58 | $69K |
| 99223 Hospital E&M - Initial | Facility | 58 | 33 | $140.09 | $8,125 |
| 99239 Hospital Discharge Management | Facility | 46 | 28 | $94.20 | $4,333 |
| 38222 Other Organ Systems | Facility | 25 | 18 | $61.31 | $1,533 |
| 38222 Other Organ Systems | Office | 20 | 17 | $149.06 | $2,981 |
| 99205 Office E&M - New | Office | 19 | 19 | $184.44 | $3,504 |
By year: 2022 $130K for 1,049 services; 2023 $246K for 5,154 services; 2024 $254K for 7,719 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly W Fitzpatrick prescribed most often to Medicare patients was Acyclovir, with 108 prescriptions and refills. In total Kelly W Fitzpatrick wrote 1,448 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 108 | 161 | 35 | $1,558 |
| Venclexta Venetoclax | 87 | 87 | 23 | $326K |
| Ciprofloxacin Hcl Generic | 84 | 102 | 29 | $2,605 |
| Potassium Chloride Generic | 83 | 100 | 26 | $860 |
| Posaconazole Generic | 69 | 73 | 22 | $87K |
| Inqovi Decitabine/Cedazuridine | 52 | 52 | 13 | $427K |
| Pantoprazole Sodium Generic | 37 | 52 | 12 | $323 |
| Eliquis Apixaban | 37 | 46 | Under 11 | $25K |
| Jakafi Ruxolitinib Phosphate | 34 | 34 | Under 11 | $356K |
| Levofloxacin Generic | 28 | 30 | 12 | $334 |
| Atovaquone Generic | 26 | 34 | Under 11 | $14K |
| Valacyclovir Valacyclovir Hcl | 25 | 31 | Under 11 | $1,978 |
| Prochlorperazine Maleate Generic | 24 | 24 | 18 | $268 |
| Furosemide Generic | 22 | 25 | Under 11 | $13.7 |
| Xospata Gilteritinib Fumarate | 21 | 21 | Under 11 | $394K |
Brand drugs: 335 claims; generic drugs: 1,113 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly W Fitzpatrick $794 ($794 in general payments such as food, travel and fees) from 14 companies. The largest payer was Daiichi Sankyo Inc. with $165.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 7 | $165 |
| GlaxoSmithKline, LLC. GSK | 4 | $149 |
| Geron Corporation GERN | 1 | $115 |
| Astellas Pharma US Inc 4503.T | 3 | $57.8 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $53.59 |
| Melinta Therapeutics, LLC | 3 | $50.23 |
| AngioDynamics, Inc. ANGO | 2 | $46.81 |
| Incyte Corporation INCY | 2 | $38.84 |
| Abbvie Inc. ABBV | 1 | $34.58 |
| Sobi, Inc SOBI.ST | 1 | $18.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.